Acetazolamide without frusemide in the treatment of post-haemorrhagic hydrocephalus.
Mercuri
E
E
Department of Paediatrics and Neonatal Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Faundez
J C
JC
Cowan
F
F
Dubowitz
L
L
D000086:Acetazolamide / Q000008:administration & dosage* / Q000009:adverse effects; D000284:Administration, Oral; D002543:Cerebral Hemorrhage / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D005665:Furosemide / Q000008:administration & dosage; D005865:Gestational Age; D006801:Humans; D006849:Hydrocephalus / Q000188:drug therapy* / Q000209:etiology; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D009460:Neurologic Examination / Q000187:drug effects; D016896:Treatment Outcome; D017287:Ventriculoperitoneal Shunt
D005665:Furosemide; D000086:Acetazolamide